Lipoprotein lipase concentration in umbilical cord blood reflects neonatal birth weight

Clin Chim Acta. 2023 Mar 1:542:117275. doi: 10.1016/j.cca.2023.117275. Epub 2023 Mar 3.

Abstract

Background: Insulin resistance (IR) is exacerbated during pregnancy via increases in insulin counterregulatory hormones. Maternal lipids are strong determinants of neonatal growth, although triglyceride-rich lipoproteins (TGRLs) cannot be transferred directly to the fetus through the placenta. The catabolism of TGRLs under physiological IR and the reduced synthesis of lipoprotein lipase (LPL) are poorly understood. We examined the association of maternal and umbilical cord blood (UCB)-LPL concentrations with maternal metabolic parameters and fetal development.

Methods: Changes in anthropometric measures and lipid-, glucose-, and insulin-related parameters, including maternal and UCB-LPL concentrations, were examined in 69 women during pregnancy. The relationship between those parameters and neonatal birth weight was assessed.

Results: Parameters reflecting glucose metabolism did not change during pregnancy, whereas those associated with lipid metabolism and IR changed markedly, particularly in the second and third trimesters. In the third trimester, the maternal LPL concentration gradually decreased, by 54%, whereas the UCB-LPL concentration was ∼2-fold higher than the maternal LPL concentration. Univariate and multivariate analyses showed that the UCB-LPL concentration was a significant determinant of neonatal birth weight, together with placental birth weight.

Conclusion: The LPL concentration in UCB reflects neonatal development under a decreased LPL concentration in maternal serum.

Keywords: Insulin resistance; Lipoprotein lipase (LPL); Neonatal development; Pregnancy; Umbilical cord blood.

MeSH terms

  • Birth Weight
  • Female
  • Fetal Blood*
  • Humans
  • Infant, Newborn
  • Insulin
  • Lipoprotein Lipase / metabolism
  • Placenta* / metabolism
  • Pregnancy

Substances

  • Lipoprotein Lipase
  • Insulin